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Foot ulceration in persons with diabetes is the most frequent precursor to 
amputation, which impairs their activities. The aim of this chapter is to describe 
factors that lead to amputation of a diabetic foot, and propose a management 
strategy to prevent major amputation. I analyzed 233 patients who were admitted at 
the National Nagasaki Medical Center between 2008 and 2017 with foot ulcer and/
or infection. We divided them into two groups: 152 patients with diabetes mellitus 
(DM) and 81 without DM. We analyzed their laboratory data, and evaluated the 
wound severity, complications of peripheral artery disease (PAD) and renal failure, 
and infection. Patients with DM ulcer were significantly more likely to receive 
amputation. Patients with DM were significantly more likely to develop infection, 
and tended to undergo emergency debridement. Among the patients with DM, the 
amputation group (85) showed significantly higher levels of CRP and WBC, and 
was more likely to develop infection, PAD, and renal failure. My results suggest that 
risk factors leading to leg amputation are severe infection and reduction of arterial 
blood flow. Early debridement to reduce infectious inflammation and angioplasty 
following free flap transfer are recommended to preserve legs.
Keywords: diabetic foot, diabetic gangrene, leg amputation, angioplasty,  
free flap transfer
1. Introduction
In the past four decades, over 42–56% of major lower extremity amputations in 
the United States and Western European countries have been due to diabetes mellitus 
(DM) [1–4]. The relative risk of major leg amputations for diabetes ranges from 5.1 
to 31.5 times in comparison with that of nondiabetic populations [5, 6]. Extensive 
efforts have been made to improve the treatment of diabetes in regard to glycemic 
control and the prevention of diabetic complications, and foot ulcer treatments 
have improved for diabetic patients [7, 8]. Before 2004, trauma accounted for most 
amputations in the majority of hospitals, followed by malignancies [9]. However, the 
most common cause of amputation at present is diabetes mellitus [10, 11].
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Amputation is the most appropriate therapy for an ischemic or infected limb, 
but the level at which to amputate is often difficult to determine. Patients who 
undergo only toe or trans-metatarsal amputation can walk on their own feet; how-
ever, those with major amputation require an artificial leg or a cane, which impairs 
their activities [12, 13]. The aim of this chapter is to describe factors that lead to 
amputation of a diabetic foot and propose a management strategy to prevent major 
amputation.
2. Materials and methods
A retrospective descriptive study including 152 diabetic patients among 233 
patients with leg ulcers who were treated in our medical center was carried out 
between January 2008 and December 2017. All patients had been diagnosed with 
type II diabetes. Diabetic foot ulcers represent more than 65 percent of all leg 
ulcers.
To clarify the clinical characteristics of the diabetic foot, a comparison of foot 
ulcer patients with and without diabetes mellitus is conducted first, risk factors 
leading to amputation in cases of diabetic foot ulcer and “major” amputation in 
cases of diabetic foot are discussed, and a recommended strategy to avoid major leg 
amputation is presented.
Statistical analysis was performed using the Wilcoxon signed-rank test and chi-
square test. The value of p < 0.05 was determined as significant.
The ethical committee of our medical center approved this study.
3. Results
3.1 Comparison of foot ulcer patients with and without diabetes mellitus
Profiles of foot ulcer patients with and without diabetes mellitus are shown in 
Table 1. Of the 233 patients with a foot ulcer, 63% (147) were men, and 37% (86) 
were women. Of course, levels of HbA1C and blood sugar in the diabetic foot 
group were significantly higher than those in the nondiabetic foot group, and 
men were more likely to develop leg ulcers in the diabetic patient group. There 
were no significant differences in CRP, WBC, serum albumin, or hemoglobin 
between the groups.
The severity of leg ulcers at discovery in patients with and without diabetes 
mellitus is shown in Table 2. In the groups, the ulcer stage based on the Wagner 
classification showed similar tendencies. About 80% of the diabetic foot group 
developed infection, being a significantly higher rate than in the nondiabetic 
foot. Methicillin-resistant Staphylococcus aureus (MRSA), methicillin-susceptible 
Staphylococcus aureus (MSSA), and Streptococcus were ranked high and accounted 
for over three-quarters of infections in both groups (Figure 1).
Because patients with diabetes are likely to develop severe infection, more than 
50% of foot ulcer patients with diabetes required immediate debridement surgery, 
being a significantly higher rate than in the nondiabetic foot group (25%) (Figure 2).
The frequencies of peripheral artery disease in foot ulcer patients with and 
without diabetes were 38.2 and 34.6%, respectively. There were no significant dif-
ferences between the groups.
The frequencies of hemodialysis in patients with and without diabetes were 7.2 
and 6.2%, respectively. There were no significant differences between the groups.
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The frequencies of amputation in foot ulcer patients with and without diabetes 
were 53.9 and 34.6%, respectively. More than half of the patients with diabetes 
underwent amputation surgery, being a significantly higher rate than that in the 
nondiabetic foot group (Figure 3).
3.2 Comparison of foot ulcer patients with and without diabetes mellitus
We evaluated 85 amputated legs in 152 diabetic foot patients. Sixty-eight percent 
(104) of the patients were men, and 32% (48) were women. Profiles of diabetic 
patients with/without leg amputation are shown in Table 3.
Men were more likely to require amputation. CRP and WBC were significantly 
higher, and serum albumin was significantly lower in the major amputation group, 
suggesting that severe infection and malnutrition are risk factors for major leg 
amputation in diabetic foot patients.
Table 1. 
Profile of foot ulcer patients with and without diabetes mellitus.
Table 2. 




Infection of leg ulcers at discovery in patients with and without diabetes mellitus (MRSA, methicillin-resistant 
Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus).
Figure 2. 
The frequency of foot ulcer patients with and without diabetes, who required immediate debridement surgery.
Figure 3. 
The frequency of amputation in foot ulcer patients with and without diabetes.
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Sixty-nine (82%) of 85 amputees and 36 (57.6%) of 67 non-amputees with 
diabetes developed infection, showing a significant difference between the groups. 
More than half of amputated and only 17.9% of non-amputated patients with 
diabetes were complicated by peripheral artery disease, showing a significant 
difference between the groups (Figure 4). Furthermore, the frequency of hemo-
dialysis in amputated patients (11.8%) was also significantly higher than that in 
non-amputated patients (1.5%) (Figure 5).
3.3  Comparison of diabetic foot ulcer patients who underwent major and minor 
leg amputation
Of the 85 amputees with diabetes, 44 patients underwent minor amputation, 
and 38 received major amputation. Seventy-one percent (58) were men and 29% 
(24) were women. Profiles of diabetic patients with/without leg amputation are 
shown in Table 4. Men were more likely to require major amputation. CRP and 
WBC were significantly higher, and serum albumin was significantly lower in the 
Table 3. 
Profiles of diabetic patients with and without leg amputation.
Figure 4. 
The frequency of amputation in diabetic foot ulcer patients with and without peripheral artery disease.
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major amputation group, suggesting that severe infection and malnutrition are risk 
factors for major leg amputation in diabetic foot patients.
4.  Risk factors leading to leg amputation and strategy to prevent major 
amputation
Diabetic foot ulcers sometimes lead to minor or major amputation, with a high 
impact on patients’ life and its quality [14]. Our results suggest that risk factors for 
leg amputation in diabetic foot patients include male, complication of severe infec-
tion, complication of peripheral artery disease, complication of hemodialysis, and 
malnutrition.
4.1 Improvement of malnutrition
The importance of nutritional support in patients with wounds has been 
examined. Malnourished patients showed not only a higher frequency of 
Figure 5. 
The frequency of amputation in diabetic foot ulcer patients with and without hemodialysis.
Table 4. 
Profiles of diabetic patients who underwent major and minor leg amputation.
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impaired wound healing but also an increased risk of postoperative cardiopul-
monary and septic complications [15, 16]. Malnutrition cannot be improved in a 
short time after developing foot ulcers. Thus, patients requiring surgical treat-
ment should also receive supplemental nourishment in the perioperative period 
[17]. Luo et al. suggested that the geriatric nutritional risk index was a reliable 
and effective predictive marker of patients’ amputation-free survival, and it 
could identify patients early with a high risk of amputation [18]. Appropriate 
blood sugar control and nutritional support are required for diabetic patients 
to prevent leg amputation. Malnutrition usually occurs in critical limb ischemia 
patients as well, because of a lack of appetite and sleeplessness due to chronic 
pain. These patients with peripheral artery disease also require pain control and 
nutritional support services [18].
4.2 Foot care for patients undergoing hemodialysis
The number of patients requiring hemodialysis has been growing because 
obesity-related renal diseases such as diabetes mellitus are increasing [19, 20]. 
Diabetic patients with renal failure had high risks of foot ulceration and lower limb 
complications [21]. Regarding cutaneous infection, Bencini et al. reported that the 
incidence of fungal infection in patients undergoing hemodialysis was 67% [22]. 
Because chronic renal failure patients exhibit impaired cellular immunity due to 
a decreased T-lymphocyte cell count, this could explain the increased prevalence 
of fungal infections [23]. Thus, difficulty healing wounds is a frequent problem 
in patients on hemodialysis [24]. Amputations of limbs are sometimes performed 
for these complex ulcers, because when patients receiving hemodialysis develop 
aggressive life-threatening infections such as sepsis, immediate surgical debride-
ment is required in order to salvage the blood access line and save lives [25]. Fujioka 
reported that 13 of 17 wounds required immediate surgery, including amputation 
and debridement in patients with DM, while only 1 of 13 required immediate 
surgery in patients without DM [26].
Poor management of foot ulcers in patients receiving hemodialysis leads to 
prolonged ulceration, gangrene, amputation, depression, and death [27].
Marn et al. investigated the association between the implementation of a routine 
foot check program in diabetic incident hemodialysis patients and concluded that 
monthly foot checks are associated with a reduction of major lower limb amputa-
tions [28]. All patients on hemodialysis should be considered as being at high risk 
of developing foot complications and undergo foot checks frequently. If infection is 
suspected, antibiotics should be administered through the dialysis line immediately 
during dialysis.
4.3 Infection control
Diabetic foot infection is a common diabetic complication, which results in 
lower limb amputation if not treated properly. Patients with diabetes are likely to 
develop infections, because of the alteration of immune defense mechanisms such 
as a change in the neutrophil function, suppression of the antioxidant system, and 
modified humoral activity due to the hyperglycemic environment [29].
Once a diabetic foot develops infection, it progresses rapidly and requires 
the removal of all necrotizing tissue involving the bone, tendons, and skin 
(Figure 6).
If the toe infection progresses and spreads widely, the patient may have to 
undergo major amputation (Figures 7a and b). Thus, early and appropriate 




Soft tissue infections in diabetic patients require multidisciplinary treatment 
including rapid surgical intervention, antibiotic treatment, and hyperbaric oxygen 
therapy to restrict the growth of pathogens [30–32]. Antibiotic therapy should be 
instituted immediately. The initial antibiotic should act on aerobic Gram-positive 
and Gram-negative bacteria but also on anaerobic bacteria. Systemic antibiotics 
have been demonstrated in many trials to be effective in treating acute diabetic foot 
infections. Tchero et al. performed a systematic review to assess the clinical efficacy 
of antibiotic regimens in the treatment of diabetic foot infections and concluded 
that piperacillin/tazobactam should be recommended for severe infections and the 
adjuvant use of topical agents with systemic antibiotics improved the outcomes 
compared with systemic antibiotics alone [33]. Mustăţea et al. suggested that an 
Figure 6. 
A view of progressing diabetic infection in the big toe, which aggravated rapidly and required the removal of 
toes and metatarsal bones within 3 weeks.
Figure 7. 
(a) A view of necrotizing fasciitis in the left forearm at the first examination, which progressed 
rapidly to the upper arm, and the patient developed septic shock in 2 days. (b) Amputation of the 
infected hand at the upper arm was immediately performed to control the aggressive infection.
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initial combination of third-generation cephalosporin, quinolone, and metronida-
zole was initially administered. After germ identification, antibiotic therapy was 
administered according to the antibiogram [29]. Cellulitis, which shows inflamma-
tion and infection of the skin and subcutaneous tissue, can be treated with systemic 
Gram-positive bactericidal antibiotics only. However, if deep tissue infection, 
especially osteomyelitis, is suspected, removal of the infected bone and soft tissue, 
followed by 2–4 weeks of antibiotics, is required [30].
4.3.2 Surgical debridement
Regarding surgical intervention, early and appropriate debridement to reduce 
infection is recommended to achieve infection control (Figure 8).
If the infection invades deeper to the tendon, the lesions can often be 
extended and spread upward rapidly along the tendon tract, which can lead to 
systematic sepsis and require immediate limb amputation (Figure 9a and b). 
As the infection developing in the diabetic patients’ limbs progresses rapidly, 
physicians must decide on whether to carry out debridement before the infected 
lesion spreads upward.
Figure 8. 
Views of debridement for necrotizing fasciitis in the diabetic patient’s right sole. All necrotizing, contaminated 
tissue was removed immediately.
Figure 9. 
(a) A view of necrotizing fasciitis in the right big toe, which spreads upward rapidly.  




Case 1. A 51-year-old man developed diabetic foot gangrene with osteomyeli-
tis of the fifth toe, which had progressed for 2 weeks (Figure 10a). The patient 
underwent fourth and fifth toe amputation immediately, and cleansing to reduce 
infection was performed for 2 weeks (Figure 10b). As abundant granulation tissue 
developed on the wound surface, he underwent free skin grafting (Figure 10c). The 
wound had completely resurfaced by 1 month after skin grafting, and the patient 
could walk without a cane (Figure 10d).
4.3.3 Angioplasty for an ischemic foot
Peripheral artery disease (PAD) is observed in up to 50% of patients with a 
diabetic foot ulcer, and the presence of PAD is an important consideration in their 
management [34]. PAD affects the distal vessels and results in occlusion, which is 
one of the major causes of ulcer development and an increased risk of amputation. 
The treatment for these patients often requires challenging distal revasculariza-
tion surgery or angioplasty to prevent limb amputation [35]. Revascularization is 
commonly performed in patients with critical limb ischemia and a diabetic foot 
ulcer, and the ulcer-healing rate after revascularization ranges from 46 to 91% [36]. 
Hinchliffe et al. reviewed the effectiveness of revascularization of the ulcerated 
foot in patients with diabetes and PAD 1 year after surgery and reported that limb 
salvage rates showed a median of 85% following open surgery, and more than 60% 
of ulcers had healed following revascularization. They concluded that revascular-
ization improved rates of limb salvage compared with the results of conservatively 
treated patients [34].
Figure 10. 
(a) Case 1. A view of diabetic foot gangrene with osteomyelitis of the fifth toe. (b) After fourth and fifth toe 
amputation, cleansing was performed for 2 weeks. (c) Intraoperative view showing free skin grafting on the 
wound. (d) A view of the foot 1 month after surgery showing favorable coverage of the wound.
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Case presentations
Case 2. A 67-year-old man developed a diabetic foot ulcer of the right heel, which 
had progressed for 2 months (Figure 11a). His posterior tibial artery was not palpable. 
Enhanced computed tomography (CT) showed that circulation of his right lower leg 
was poor, with an ankle brachial pressure index (ABI) of only 0.53, which suggested 
that his leg ulcer might not heel spontaneously. We fashioned femoral-popliteal artery 
(FP) bypass to increase distal blood flow, and ABI improved to 0.83(Figure 11b). As the 
patient’s foot received sufficient flow, he could safely undergo resurfacing surgery using 
a reversed sural flap successfully and could walk 3 months after surgery (Figure 11c–f).
Figure 11. 
(a) Case 2. A view of a diabetic foot ulcer of the right heel. (b) Enhanced computed tomography scan image 
showing the poor circulation of the patient’s right lower leg due to obstruction of the right femoral artery 
(circles). After fashioning the femoral-popliteal artery bypass, increased distal blood flow was seen (small 
arrows). (c) Intraoperative view showing the debrided heel ulcer and design of the reversed sural flap.  
(d) Intraoperative view of heel reconstruction showing the transferred reversed sural flap. (e) A view of the 




Case 3. A 60-year-old man developed a diabetic foot ulcer and osteomyelitis of 
the calcaneus (Figure 12a). Following the removal of a sequester, he underwent FP 
bypass angioplasty, and ABI improved from 0.67 to 1.01 (Figure 12b). The bone-
exposing wound was resurfaced using a free superficial circumflex iliac perforator 
(SCIP) flap (Figure 12c–e). One year after the surgery, good circulation had been 
achieved without infection or ulcer relapse (Figure 12f).
4.3.4 Advantages of resurfacing the amputation stump with a free flap
Standard stump plasty requires shortening of the remaining fine and vivid bone 
end to resurface the bone-exposing amputation stump (Figure 13a and b).
Figure 12. 
(a) Case 3. A view of a diabetic foot ulcer and osteomyelitis of the calcaneus. (b) Enhanced computed 
tomography scan image showing poor circulation of the patient’s right lower leg due to obstruction of right 
femoral artery (circle). After fashioning the femoral-popliteal artery bypass, increased distal blood flow was 
seen. (c) Intraoperative view showing the design of a free superficial circumflex iliac perforator flap. (d) 
Intraoperative view of the elevated SCIP flap. The arrow indicates the perforator of superficial circumflex iliac 
vessels. (e) Intraoperative view of the harvested SCIP flap. (f) A view of the reconstructed foot 1 year after 
surgery showing favorable coverage of the wound.
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On the other hand, free flap transfer enables surgeons to maintain the bone 
length, which is a potential advantage, especially when amputation is performed at 
the trans-metatarsal lesion (Figure 14a–c).
This is because Chopart or transtibial amputation results in more debilitating 
functional outcomes than transmetatarsal amputation. Furthermore, transmetatar-
sal amputation preserves maximal foot length, allowing patients to achieve a better 
quality of life [37, 38].
Regarding the flap choice, the ideal flap is thought to be a good vascularized skin 
paddle with the same thickness and width as the wound and requiring a single-stage 
operation [39]. Perforator flaps are defined as flaps consisting of skin and/or sub-
cutaneous fat, with a blood supply from isolated perforating vessels of a stem artery 
[40]. The development of perforator flaps has increased the number of potential 
donor sites because a flap can be supplied by any musculocutaneous perforator, and 
donor-site morbidity can be reduced [41, 42]. Furthermore, the advantage of this 
skin flap is that it is less invasive, so that the operation can be performed under local 
anesthesia if the wound is small.
Case presentation
Case 4. A 32-year-old man developed a diabetic foot ulcer on the step 
(Figure 15a). Following debridement, he underwent resurfacing surgery using a 
free superficial circumflex Iliac artery perforator flap (Figure 12b and c). As free 
SCIP flap transfer is less invasive, the operation can be performed under local anes-
thesia (Figure 15d). One year after the surgery, good circulation had been achieved 
without infection or ulcer relapse (Figure 15e).
The SCIP flap is recommended because it minimizes sacrifice at the donor site, 
causing no damage to the main vessels or muscles beneath the flap. The only disadvan-
tage is that the pedicle vessel is sometimes short when a suitable recipient vessel cannot 
Figure 13. 
(a) A view of diabetic gangrene extending the first and second metatarsal bones. After removal of 
the necrotic bone, the navicular was exposed. (b) Intraoperative view of Chopart amputation followed by 




(a) A view of a diabetic foot ulcer with osteomyelitis of the first and second metatarsal bones.  
(b) Intraoperative view of the harvested anterolateral thigh (ALT) flap. (c) A view of the reconstructed foot using 
a free ALT flap 1 year after surgery, showing favorable coverage, and the patient could walk without a cane.
Figure 15. 
(a) Case 4. A view of a diabetic foot ulcer of the step. (b) Intraoperative view showing the design of a free 
superficial circumflex iliac perforator flap. (c) Intraoperative view showing the design of a free SCIP flap. 
(d) Intraoperative view showing that an SCIP flap transfer is less invasive, so the patient was awake and 
talking with the surgeon. (e) A view of the reconstructed foot 2 months after surgery revealed favorable wound 
coverage.
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be found near the wound [43]. Identifying an acceptable recipient vessel around the 
contaminated area is not always easy. Chronic inflammation in recipient vessels caused 
by infection and fibrosis may be one of the factors leading to thrombosis of the anasto-
mosed vessel [44]. So, it is important to select a flap with a long pedicle, as the suitable 
recipient vessel may be distant from the wound. The anterolateral thigh (ATL) flap is 
often chosen because it is supplied by the descending branch of the lateral femoral 
circumflex artery, which has an external diameter of more than 2 mm at the proximal 
end with a pedicle of more than 8 cm in length [45, 46]. This flap is also a perforator 
flap, so that a larger cutaneous or fasciocutaneous flap can be harvested from the thigh 
while avoiding the sacrificing of underlying muscle and large vessels [47, 48].
Case presentation
Case 5. A 66-year-old man developed a diabetic foot ulcer with osteomyelitis of 
the left fourth and fifth toes (Figure 16a). He had already undergone right below 
Figure 16. 
(a) Case 5. A view of a diabetic foot ulcer. The fourth and fifth toes were amputated due to osteomyelitis.  
(b) Intraoperative view showing the elevation of an anterolateral thigh (ALT) flap. (c) Intraoperative view 
showing resurfacing of the bone-exposing wound with an ALT flap. (d) A view of the reconstructed foot 
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the knee amputation due to diabetic gangrene. Thus, he desired to preserve his left 
leg to walk. Following debridement, he underwent resurfacing surgery using a free 
ALT flap (Figure 16b and c). Two months after the surgery, good resurfacing had 
been achieved, and he could walk with an artificial right leg (Figure 16d).
5. Conclusion
I conclude that the risk factors of leg amputation due to a diabetic foot are 
complications of severe infection and PAD, so diabetic ulcer management should 
include the immediate removal of necrotic tissue and control of infection. The only 
way to prevent major amputation of a diabetic ischemic foot is angioplasty of the 
occluded lower extremity arteries, and reconstruction of the amputation stump 
using free flap transfers to preserve the foot length is a good option for preserving 
the walking function.
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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